Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advanced glycation end product receptor-mediated cellular dysfunction.

Angelika Bierhaus1, Per M Humpert, David M Stern

  • 1University of Heidelberg, Department of Medicine I, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. angelika_bierhaus@med.uni-heidelberg.de

Annals of the New York Academy of Sciences
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postprandial Symptoms in a Mixed-Meal-Test after Bariatric Surgery: Clinical Experience and a Critical Review of Dumping Syndrome Definition and Management.

Obesity facts·2024
Same author

Continuous glucose monitoring as a close to real life alternative to meal studies - a pilot study with a functional drink containing amino acids and chromium.

Frontiers in medical technology·2022
Same author

Protective Effects of Transient Glucose Exposure in Adult <i>C. elegans</i>.

Antioxidants (Basel, Switzerland)·2022
Same author

A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study.

PloS one·2020
Same author

Impaired dexamethasone resorption in two patients with pseudo-Cushing after bariatric surgery: Implications for immunosuppressive treatment.

Clinical obesity·2020
Same author

Pianp deficiency links GABA<sub>B</sub> receptor signaling and hippocampal and cerebellar neuronal cell composition to autism-like behavior.

Molecular psychiatry·2019

Advanced glycation end products (AGEs) and RAGE signaling drive chronic inflammation. Soluble RAGE (sRAGE) offers protection, but RAGE-deficient mice show less benefit, suggesting other receptors are involved.

Area of Science:

  • Biochemistry
  • Immunology
  • Pathophysiology

Background:

  • Advanced glycation end products (AGEs), S100/calgranulins, and HMGB1 proteins are implicated in chronic inflammatory diseases like diabetes mellitus.
  • These molecules promote cellular dysfunction by binding to cell surface receptors, notably the receptor for AGEs (RAGE).
  • RAGE engagement converts transient cellular activation into sustained dysfunction, a key mechanism in chronic diseases.

Purpose of the Study:

  • To investigate the role of RAGE and its ligands in chronic inflammation and cellular dysfunction.
  • To compare the protective effects of soluble RAGE (sRAGE) against RAGE deficiency in disease models.
  • To explore potential alternative receptor pathways activated by abundant RAGE ligands.

Main Methods:

Related Experiment Videos

  • Utilizing animal models, including RAGE knockout (RAGE-/-) mice.
  • Administering soluble RAGE (sRAGE) to block ligand-RAGE interactions.
  • Assessing cellular activation, dysfunction, and immune responses in different experimental settings.

    • Main Results:

    • Blockade of ligand-RAGE interaction with sRAGE effectively suppresses chronic cellular activation and dysfunction in animal models.
    • RAGE-/- mice exhibit less protection compared to sRAGE treatment, indicating sRAGE's broader impact.
    • sRAGE can protect RAGE-/- mice in specific adaptive immune response contexts, suggesting RAGE-independent mechanisms.

    Conclusions:

    • While RAGE is central to chronic inflammation, its ligands may also activate other receptors.
    • sRAGE demonstrates significant therapeutic potential beyond simply blocking RAGE, possibly by interacting with other pathways.
    • Further research is needed to identify these alternative receptors and their roles in RAGE-mediated diseases.